News tagged ‘Genomics’ clear
- Dr. David Steensma says new genomic studies cataloging the mutations that drive two deadly cancers is a landmark that will stand the test of time.
Tags: Genomics, Leukemia
- Dr. John Quackenbush discusses the collaboration of GenoSpace and the Multiple Myeloma Research Foundation to advance cancer research and development. GenoSpace provides tools for genomics research.
Tags: Genomics, MultipleMyeloma
- The National Cancer Institute reported successes in the effort to overhaul the publicly funded clinical trials system. Dr. Levi Garraway pointed to the extraordinary possibilities and challenges of designing cutting-edge trials using genomic profiling.
Tags: Genomics
- Cambridge-based Foundation Medicine is bringing high-tech tools to the battle against cancer. Founded in 2009 by leaders in genome technology including Dana-Farber, the company is analyzing patients' tumors for the entire coding sequence of 200-plus genes known to be altered in human cancers.
Tags: Genomics
- Dr. Bruce E. Johnson said researchers at Foundation Medicine in Cambridge, Mass., have been routinely testing for certain "alterations" in cancer cells to help target treatments and new technologies.
Tags: Genomics, TargetedTherapy
- Judy Garber, MD, MPH, discussed the potential clinical implications of the findings from a study from The Cancer Genome Atlas that identified four genetically distinct types of breast cancer.
Tags: BreastCancer, Genomics
- Dana-Farber researchers were part of The Cancer Genome Atlas study that identified four genetically distinct types of breast cancer, each with its own biology and survival outlooks. Matthew Meyerson, MD, PhD, one of the study's co-authors, said the findings could help direct the development of better treatments, adding that it likely will result in new combination therapies rather than one "silver bullet" drug.
Tags: BreastCancer, Genomics
- Epigenetics was the subject of a particularly interesting session, held on April 1st, at a meeting of the American Association for Cancer Research in Chicago. James Bradner, MD, described how his group has shown that a substance known as JQ1, which inhibits an epigenetic regulator called BRD4, blocks the activity of a gene by the name of Myc.
Tags: Genomics